 Joseph Sakai
Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conduct Disorder | 27 | 2023 | 193 | 8.550 |
Why?
| | Substance-Related Disorders | 29 | 2023 | 947 | 4.120 |
Why?
| | Adolescent Behavior | 8 | 2023 | 489 | 2.460 |
Why?
| | Emotions | 10 | 2023 | 472 | 2.120 |
Why?
| | Antisocial Personality Disorder | 12 | 2023 | 156 | 1.870 |
Why?
| | Empathy | 7 | 2023 | 139 | 1.600 |
Why?
| | Morals | 2 | 2023 | 65 | 1.410 |
Why?
| | Cannabis | 4 | 2023 | 384 | 1.400 |
Why?
| | Students, Medical | 4 | 2023 | 262 | 1.380 |
Why?
| | Mental Disorders | 8 | 2021 | 892 | 1.250 |
Why?
| | Risk-Taking | 8 | 2023 | 333 | 1.200 |
Why?
| | Helping Behavior | 2 | 2019 | 16 | 1.160 |
Why?
| | Adolescent | 45 | 2023 | 17848 | 1.130 |
Why?
| | Connectome | 2 | 2023 | 63 | 1.020 |
Why?
| | Brain | 10 | 2023 | 2371 | 1.010 |
Why?
| | Altruism | 2 | 2023 | 25 | 0.980 |
Why?
| | Opioid-Related Disorders | 3 | 2023 | 413 | 0.960 |
Why?
| | Medical Marijuana | 3 | 2017 | 97 | 0.940 |
Why?
| | Clinical Clerkship | 2 | 2023 | 72 | 0.940 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 3 | 2010 | 72 | 0.890 |
Why?
| | Psychiatry | 3 | 2023 | 154 | 0.880 |
Why?
| | Theory of Mind | 1 | 2023 | 9 | 0.850 |
Why?
| | Alcoholism | 10 | 2014 | 713 | 0.850 |
Why?
| | Psychology, Adolescent | 2 | 2016 | 63 | 0.840 |
Why?
| | Binge Drinking | 1 | 2023 | 32 | 0.830 |
Why?
| | Cerebral Cortex | 5 | 2017 | 380 | 0.780 |
Why?
| | Decision Making | 7 | 2017 | 782 | 0.780 |
Why?
| | Models, Psychological | 1 | 2023 | 297 | 0.760 |
Why?
| | Marijuana Abuse | 5 | 2017 | 212 | 0.750 |
Why?
| | Vaping | 1 | 2022 | 45 | 0.730 |
Why?
| | Tobacco Products | 1 | 2022 | 98 | 0.720 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 71 | 0.710 |
Why?
| | Magnetic Resonance Imaging | 15 | 2023 | 3053 | 0.690 |
Why?
| | Prescription Drug Misuse | 1 | 2020 | 38 | 0.660 |
Why?
| | Education, Medical | 1 | 2021 | 215 | 0.620 |
Why?
| | Humans | 69 | 2023 | 114689 | 0.620 |
Why?
| | Male | 50 | 2023 | 55599 | 0.600 |
Why?
| | Gray Matter | 2 | 2015 | 67 | 0.590 |
Why?
| | Case-Control Studies | 11 | 2023 | 3003 | 0.560 |
Why?
| | Female | 45 | 2023 | 59511 | 0.550 |
Why?
| | Gift Giving | 1 | 2016 | 9 | 0.520 |
Why?
| | Affective Symptoms | 1 | 2016 | 47 | 0.510 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2014 | 1880 | 0.500 |
Why?
| | Suicide | 1 | 2021 | 506 | 0.500 |
Why?
| | Cognition | 4 | 2023 | 989 | 0.490 |
Why?
| | Problem Behavior | 1 | 2015 | 86 | 0.450 |
Why?
| | Receptors, GABA-A | 2 | 2014 | 82 | 0.430 |
Why?
| | Alcohol Drinking | 4 | 2023 | 651 | 0.420 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 23 | 0.390 |
Why?
| | Marijuana Smoking | 2 | 2014 | 224 | 0.380 |
Why?
| | Sex Characteristics | 3 | 2023 | 641 | 0.380 |
Why?
| | Psychomotor Performance | 1 | 2013 | 280 | 0.370 |
Why?
| | Nerve Net | 1 | 2013 | 226 | 0.360 |
Why?
| | Ethanol | 2 | 2023 | 538 | 0.350 |
Why?
| | Social Behavior | 1 | 2012 | 267 | 0.330 |
Why?
| | Receptors, Dopamine D2 | 2 | 2007 | 86 | 0.330 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 5 | 2009 | 230 | 0.310 |
Why?
| | Games, Experimental | 2 | 2019 | 9 | 0.290 |
Why?
| | Legislation, Drug | 2 | 2022 | 78 | 0.290 |
Why?
| | Neuroimaging | 3 | 2019 | 249 | 0.270 |
Why?
| | Reproducibility of Results | 5 | 2023 | 2765 | 0.270 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 113 | 0.260 |
Why?
| | Young Adult | 8 | 2023 | 10470 | 0.260 |
Why?
| | Aggression | 2 | 2009 | 183 | 0.260 |
Why?
| | Reward | 3 | 2019 | 211 | 0.260 |
Why?
| | Colorado | 9 | 2020 | 4099 | 0.250 |
Why?
| | Adult | 21 | 2023 | 30550 | 0.250 |
Why?
| | Blood Chemical Analysis | 1 | 2006 | 90 | 0.250 |
Why?
| | Substance Abuse Detection | 1 | 2006 | 62 | 0.250 |
Why?
| | Monitoring, Ambulatory | 1 | 2006 | 81 | 0.240 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 685 | 0.230 |
Why?
| | Brain Mapping | 5 | 2019 | 524 | 0.230 |
Why?
| | United States | 10 | 2022 | 12183 | 0.230 |
Why?
| | Polymorphism, Genetic | 1 | 2006 | 610 | 0.220 |
Why?
| | Guilt | 1 | 2023 | 11 | 0.220 |
Why?
| | Charities | 1 | 2023 | 9 | 0.220 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 262 | 0.220 |
Why?
| | Marriage | 1 | 2004 | 106 | 0.220 |
Why?
| | Siblings | 3 | 2009 | 221 | 0.210 |
Why?
| | Happiness | 1 | 2022 | 20 | 0.200 |
Why?
| | Impulsive Behavior | 2 | 2015 | 113 | 0.200 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1131 | 0.200 |
Why?
| | Child | 12 | 2022 | 18415 | 0.200 |
Why?
| | Odds Ratio | 2 | 2020 | 953 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 2 | 2008 | 2086 | 0.200 |
Why?
| | Faculty | 1 | 2023 | 130 | 0.190 |
Why?
| | Unsafe Sex | 2 | 2020 | 58 | 0.190 |
Why?
| | Electronics | 1 | 2022 | 67 | 0.190 |
Why?
| | Family | 4 | 2009 | 589 | 0.190 |
Why?
| | Affect | 1 | 2023 | 246 | 0.190 |
Why?
| | Educational Measurement | 1 | 2023 | 243 | 0.180 |
Why?
| | Phenotype | 4 | 2010 | 2796 | 0.180 |
Why?
| | Social Stigma | 1 | 2021 | 87 | 0.180 |
Why?
| | Enuresis | 1 | 2000 | 3 | 0.170 |
Why?
| | Fear | 1 | 2022 | 293 | 0.170 |
Why?
| | Patient Acceptance of Health Care | 1 | 2005 | 681 | 0.170 |
Why?
| | Substance Abuse, Intravenous | 2 | 2013 | 99 | 0.170 |
Why?
| | Education, Distance | 1 | 2019 | 38 | 0.160 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 65 | 0.160 |
Why?
| | Tobacco Use | 1 | 2020 | 60 | 0.160 |
Why?
| | Prevalence | 6 | 2014 | 2251 | 0.160 |
Why?
| | Data Collection | 2 | 2014 | 620 | 0.160 |
Why?
| | Logistic Models | 3 | 2020 | 1841 | 0.160 |
Why?
| | Craving | 1 | 2019 | 32 | 0.160 |
Why?
| | Physician Incentive Plans | 1 | 2018 | 6 | 0.160 |
Why?
| | Mental Health | 2 | 2021 | 562 | 0.160 |
Why?
| | Multimodal Imaging | 1 | 2019 | 88 | 0.160 |
Why?
| | Sex Factors | 4 | 2017 | 1715 | 0.160 |
Why?
| | Clinical Competence | 2 | 2023 | 893 | 0.160 |
Why?
| | Adolescent Development | 1 | 2019 | 83 | 0.160 |
Why?
| | Professional-Patient Relations | 1 | 2019 | 141 | 0.150 |
Why?
| | Tuberculin Test | 1 | 1998 | 32 | 0.150 |
Why?
| | Automobile Driving | 1 | 2020 | 128 | 0.150 |
Why?
| | Linkage Disequilibrium | 3 | 2008 | 245 | 0.150 |
Why?
| | Surveys and Questionnaires | 6 | 2018 | 4623 | 0.150 |
Why?
| | Violence | 1 | 2019 | 202 | 0.140 |
Why?
| | Cross-Sectional Studies | 5 | 2020 | 4410 | 0.140 |
Why?
| | Comorbidity | 7 | 2015 | 1448 | 0.140 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1998 | 112 | 0.140 |
Why?
| | Genotype | 4 | 2014 | 1760 | 0.140 |
Why?
| | Suicidal Ideation | 1 | 2021 | 401 | 0.140 |
Why?
| | Physicians, Family | 1 | 2018 | 201 | 0.140 |
Why?
| | Writing | 1 | 2018 | 82 | 0.140 |
Why?
| | Suicide, Attempted | 1 | 2020 | 317 | 0.140 |
Why?
| | Marijuana Use | 1 | 2020 | 167 | 0.140 |
Why?
| | Organ Size | 2 | 2015 | 436 | 0.140 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2000 | 196 | 0.140 |
Why?
| | Psychotic Disorders | 1 | 1998 | 118 | 0.140 |
Why?
| | Drug Prescriptions | 1 | 2018 | 239 | 0.140 |
Why?
| | Parents | 1 | 2004 | 1186 | 0.130 |
Why?
| | California | 1 | 2017 | 353 | 0.130 |
Why?
| | Moral Obligations | 1 | 2016 | 10 | 0.130 |
Why?
| | Self Report | 2 | 2020 | 696 | 0.130 |
Why?
| | Photic Stimulation | 1 | 2017 | 203 | 0.130 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 493 | 0.130 |
Why?
| | Mental Competency | 1 | 2015 | 26 | 0.130 |
Why?
| | Genetics, Population | 2 | 2007 | 188 | 0.130 |
Why?
| | Research Subjects | 1 | 2015 | 40 | 0.130 |
Why?
| | Learning | 1 | 2019 | 350 | 0.120 |
Why?
| | Frontal Lobe | 2 | 2015 | 141 | 0.120 |
Why?
| | Biological Specimen Banks | 1 | 2015 | 94 | 0.120 |
Why?
| | Gambling | 1 | 2015 | 31 | 0.120 |
Why?
| | Patient Satisfaction | 1 | 2018 | 578 | 0.120 |
Why?
| | Risk Factors | 6 | 2013 | 8632 | 0.120 |
Why?
| | Informed Consent | 1 | 2015 | 161 | 0.120 |
Why?
| | Accidents, Traffic | 1 | 2014 | 170 | 0.100 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2007 | 65 | 0.100 |
Why?
| | Juvenile Delinquency | 3 | 2008 | 103 | 0.100 |
Why?
| | Longitudinal Studies | 5 | 2014 | 2387 | 0.100 |
Why?
| | Limbic System | 1 | 2012 | 43 | 0.100 |
Why?
| | Attitude | 1 | 2014 | 229 | 0.100 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2019 | 133 | 0.100 |
Why?
| | Curriculum | 1 | 2018 | 819 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 771 | 0.090 |
Why?
| | Genomics | 1 | 2015 | 635 | 0.090 |
Why?
| | DNA Primers | 2 | 2010 | 510 | 0.090 |
Why?
| | Age Factors | 2 | 2014 | 2894 | 0.090 |
Why?
| | Hawaii | 1 | 2010 | 38 | 0.080 |
Why?
| | Middle Aged | 8 | 2020 | 26737 | 0.080 |
Why?
| | Urban Population | 1 | 2012 | 397 | 0.080 |
Why?
| | Nuclear Family | 1 | 2009 | 49 | 0.080 |
Why?
| | Sexual Behavior | 1 | 2013 | 440 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 477 | 0.080 |
Why?
| | Primary Health Care | 1 | 2018 | 1513 | 0.080 |
Why?
| | Base Sequence | 2 | 2010 | 2114 | 0.070 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 41 | 0.070 |
Why?
| | Diseases in Twins | 1 | 2009 | 174 | 0.070 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 16 | 0.070 |
Why?
| | Acculturation | 1 | 2007 | 50 | 0.070 |
Why?
| | Mouth Mucosa | 1 | 2007 | 79 | 0.070 |
Why?
| | Taq Polymerase | 1 | 2006 | 10 | 0.070 |
Why?
| | Inheritance Patterns | 1 | 2006 | 45 | 0.070 |
Why?
| | Twins, Dizygotic | 1 | 2007 | 182 | 0.070 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 129 | 0.070 |
Why?
| | Twins, Monozygotic | 1 | 2007 | 210 | 0.070 |
Why?
| | Hospitals, Veterans | 1 | 2007 | 244 | 0.070 |
Why?
| | Water Loss, Insensible | 1 | 2006 | 2 | 0.070 |
Why?
| | Attitude of Health Personnel | 2 | 2018 | 975 | 0.060 |
Why?
| | Residential Treatment | 1 | 2006 | 30 | 0.060 |
Why?
| | Breath Tests | 1 | 2006 | 82 | 0.060 |
Why?
| | Alcoholic Intoxication | 1 | 2006 | 62 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 743 | 0.060 |
Why?
| | Demography | 1 | 2006 | 260 | 0.060 |
Why?
| | Regression Analysis | 1 | 2007 | 945 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2006 | 4411 | 0.060 |
Why?
| | Alleles | 1 | 2007 | 789 | 0.060 |
Why?
| | Tobacco Use Disorder | 1 | 2006 | 234 | 0.060 |
Why?
| | Acute Coronary Syndrome | 1 | 2007 | 253 | 0.060 |
Why?
| | Smoking | 2 | 2012 | 1383 | 0.060 |
Why?
| | Administration, Inhalation | 1 | 2006 | 641 | 0.060 |
Why?
| | Hospitals, University | 1 | 2004 | 172 | 0.060 |
Why?
| | Equipment Design | 1 | 2006 | 508 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 718 | 0.060 |
Why?
| | Statistics, Nonparametric | 1 | 2004 | 385 | 0.050 |
Why?
| | Adaptation, Psychological | 1 | 2007 | 547 | 0.050 |
Why?
| | DNA | 2 | 2007 | 1352 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 1842 | 0.050 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1313 | 0.050 |
Why?
| | Depressive Disorder, Major | 1 | 2004 | 301 | 0.050 |
Why?
| | Psychometrics | 3 | 2009 | 608 | 0.050 |
Why?
| | Interview, Psychological | 2 | 2012 | 86 | 0.040 |
Why?
| | Substance Abuse Treatment Centers | 2 | 2012 | 42 | 0.040 |
Why?
| | Adenoidectomy | 1 | 2000 | 60 | 0.040 |
Why?
| | Child Abuse | 1 | 2004 | 456 | 0.040 |
Why?
| | HIV Infections | 1 | 2013 | 2469 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 83 | 0.040 |
Why?
| | Tonsillectomy | 1 | 2000 | 72 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 54 | 0.040 |
Why?
| | Attention | 1 | 2021 | 393 | 0.040 |
Why?
| | Health Surveys | 2 | 2012 | 443 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 259 | 0.040 |
Why?
| | Epidemics | 1 | 2018 | 69 | 0.040 |
Why?
| | Internal-External Control | 1 | 2017 | 66 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2004 | 2540 | 0.030 |
Why?
| | Cues | 1 | 2019 | 300 | 0.030 |
Why?
| | Receptors, Serotonin | 1 | 1996 | 32 | 0.030 |
Why?
| | Education, Medical, Undergraduate | 1 | 2018 | 159 | 0.030 |
Why?
| | Game Theory | 1 | 2015 | 9 | 0.030 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2015 | 21 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6116 | 0.030 |
Why?
| | Motivation | 1 | 2018 | 494 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2020 | 6347 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2008 | 1693 | 0.030 |
Why?
| | Radiography | 1 | 2015 | 812 | 0.030 |
Why?
| | Heroin Dependence | 1 | 2012 | 22 | 0.030 |
Why?
| | Condoms | 1 | 2013 | 113 | 0.030 |
Why?
| | Amphetamine-Related Disorders | 1 | 2012 | 28 | 0.030 |
Why?
| | Gyrus Cinguli | 1 | 2012 | 70 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2006 | 9088 | 0.020 |
Why?
| | Family Conflict | 1 | 2012 | 36 | 0.020 |
Why?
| | Sexual Partners | 1 | 2013 | 161 | 0.020 |
Why?
| | Schizophrenia | 1 | 1996 | 414 | 0.020 |
Why?
| | Family Relations | 1 | 2012 | 85 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2012 | 107 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 993 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2007 | 12551 | 0.020 |
Why?
| | Neural Pathways | 1 | 2012 | 261 | 0.020 |
Why?
| | Patient Admission | 1 | 2012 | 176 | 0.020 |
Why?
| | Aged | 3 | 2020 | 19074 | 0.020 |
Why?
| | Social Environment | 1 | 2012 | 283 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1177 | 0.020 |
Why?
| | Cerebellum | 1 | 2011 | 200 | 0.020 |
Why?
| | Prospective Studies | 2 | 2013 | 6220 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1430 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 131 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2012 | 927 | 0.020 |
Why?
| | Hippocampus | 1 | 2012 | 693 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 2968 | 0.020 |
Why?
| | Sex Distribution | 1 | 2007 | 337 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 321 | 0.020 |
Why?
| | Age of Onset | 1 | 2006 | 446 | 0.020 |
Why?
| | Health Services Research | 1 | 2007 | 371 | 0.010 |
Why?
| | Models, Genetic | 1 | 2007 | 562 | 0.010 |
Why?
| | Survival Analysis | 1 | 2007 | 1211 | 0.010 |
Why?
| | Nicotine | 1 | 2006 | 265 | 0.010 |
Why?
| | United States Department of Veterans Affairs | 1 | 2007 | 561 | 0.010 |
Why?
| | Perception | 1 | 2006 | 311 | 0.010 |
Why?
| | Schools | 1 | 2006 | 399 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2007 | 776 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1421 | 0.010 |
Why?
| | Incidence | 1 | 2008 | 2313 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1469 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2007 | 927 | 0.010 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 1996 | 19 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1996 | 2785 | 0.010 |
Why?
|
|
Sakai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|